Loading...
BVMF
PNVL3
Market cap225mUSD
Jun 05, Last price  
8.45BRL
1D
-1.05%
1Q
3.05%
Jan 2017
-62.11%
Name

Dimed SA Distribuidora de Medicamentos

Chart & Performance

D1W1MN
P/E
11.93
P/S
0.25
EPS
0.71
Div Yield, %
2.81%
Shrs. gr., 5y
1.90%
Rev. gr., 5y
12.65%
Revenues
4.94b
+10.79%
733,526,000832,805,000933,239,0001,074,630,0001,190,659,0001,345,632,0001,524,000,0003,480,840,0001,887,076,0001,986,026,0004,257,464,0002,258,246,0002,432,246,0002,724,680,0002,819,110,0003,225,408,0003,990,475,0004,461,017,0004,942,462,000
Net income
106m
+13.57%
14,402,00014,173,0009,689,00029,697,00030,773,00037,422,00047,105,00056,145,00049,359,00045,268,00053,059,00059,798,00074,982,00076,755,00056,151,00079,426,00086,345,00092,905,000105,509,000
CFO
224m
-24.33%
10,209,00039,609,0008,081,00050,593,00019,237,00062,298,00022,902,00071,447,000101,603,00040,885,000109,880,000128,796,000130,983,000131,859,000205,480,000296,621,000224,449,000
Dividend
Oct 03, 20240.090381 BRL/sh
Earnings
Aug 12, 2025

Profile

Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermocosmetics in Brazil. It operates in Retail and Wholesale segments. The company offers products through distribution centers in the states of Rio Grande do Sul, Paraná, and Espírito Santo. It operates 517 stores in Rio Grande do Sul, Santa Catarina, Paraná, and São Paulo. The company was formerly known as Panvel S.A. Drogarias e Farmacias and changed its name to Dimed S.A. Distribuidora de Medicamentos in April 2000. The company is headquartered in Eldorado do Sul, Brazil.
URL
https://www.panvel.com/
IPO date
Oct 29, 1992
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
4,942,462
10.79%
4,461,017
11.79%
3,990,475
23.72%
Cost of revenue
3,660,025
4,343,972
2,968,078
Unusual Expense (Income)
NOPBT
1,282,437
117,045
1,022,397
NOPBT Margin
25.95%
2.62%
25.62%
Operating Taxes
7,055
(1,321)
(7,915)
Tax Rate
0.55%
NOPAT
1,275,382
118,366
1,030,312
Net income
105,509
13.57%
92,905
7.60%
86,345
8.71%
Dividends
(33,165)
(28,721)
(24,752)
Dividend yield
2.53%
1.44%
1.64%
Proceeds from repurchase of equity
(2,997)
1,360
(160)
BB yield
0.23%
-0.07%
0.01%
Debt
Debt current
292,728
266,896
270,488
Long-term debt
1,624,225
1,395,943
1,237,768
Deferred revenue
(1,167)
Other long-term liabilities
15,002
13,851
15,678
Net debt
1,827,670
1,414,056
1,482,537
Cash flow
Cash from operating activities
224,449
296,621
205,480
CAPEX
(122,724)
(114,419)
(181,637)
Cash from investing activities
(55,693)
(196,558)
(131,085)
Cash from financing activities
(116,714)
(97,825)
(103,115)
FCF
952,402
243,267
806,005
Balance
Cash
213,408
245,389
157,355
Long term investments
(124,125)
3,394
(131,636)
Excess cash
25,732
Stockholders' equity
982,568
1,201,998
1,137,530
Invested Capital
2,485,521
2,184,222
1,963,630
ROIC
54.62%
5.71%
56.01%
ROCE
51.60%
5.30%
52.04%
EV
Common stock shares outstanding
149,114
149,717
149,145
Price
8.80
-34.13%
13.36
31.76%
10.14
-23.87%
Market cap
1,312,206
-34.40%
2,000,220
32.26%
1,512,330
-24.26%
EV
3,139,876
3,414,276
2,994,867
EBITDA
1,492,640
317,199
1,206,965
EV/EBITDA
2.10
10.76
2.48
Interest
104,880
102,573
70,025
Interest/NOPBT
8.18%
87.64%
6.85%